NL
DE
A Foundation Fighting Blindness Award of $ 2,5 million
The Foundation Fighting Blindness (USA) has awarded a Program Project Award of $ 2,5 million to Ronald Roepman, theme Renal disorders, and collaborators from Tübingen, Mainz, and London.
In the next five years, they will deploy systems pharmacology to target disrupted proteostasis in retinal ciliopathies, inherited retinal dystrophies caused by malfunctioning sensory cilia.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Grants for heart and kidney research Two awards to Radboudumc in Open Competition ENW-XS
21 July 2022Two researchers from the Radboudumc receive a grant from the NWO within the Open Competition of the Exact and Natural Sciences. They are Thijs Eijsvogels, who studies the heart, and Pieter Leermakers, who studies the kidneys.
read more
Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij
1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria. read more
Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling
11 May 2022 Bart Smeets, Jitske Jansen and collegues, theme Renal disorders published this article in the Human Development. read more
Renee Salz wins prize for best presentation
10 May 2022 Renee Salz won the award for best oral presentation during the Rolduc genetics retreat, organized by the Dutch and Belgian Societies of Human Genetics in Brugge. Her presentation was titled "Variant effect prediction based on long read transcriptomes". read more
Gene controls the formation of photosensitive disks in retinal cells
21 April 2020 Researchers have unraveled a molecular mechanism that regulates the build-up of the photosensitive segments in the cones and rods in the retina. A protein PCARE, controls this process. These new insights, published in PNAS USA, could make a significant contribution to new therapies for eye diseases. read more
